Saxon Interests Inc. Acquires Shares of 4,087 CVS Health Co. (NYSE:CVS)

Saxon Interests Inc. bought a new position in shares of CVS Health Co. (NYSE:CVS) during the fourth quarter, Holdings Channel.com reports. The fund bought 4,087 shares of the pharmacy operator’s stock, valued at approximately $323,000.

A number of other large investors have also added to or reduced their stakes in the business. Live Oak Investment Partners bought a new stake in CVS Health in the 4th quarter valued at $25,000. Atticus Wealth Management LLC grew its stake in shares of CVS Health by 149.0% in the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 219 shares in the last quarter. Cornerstone Planning Group LLC increased its position in CVS Health by 111.5% during the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 243 shares during the period. PCA Investment Advisory Services Inc. bought a new stake in CVS Health in the 2nd quarter valued at about $37,000. Finally, ZRC Wealth Management LLC grew its position in shares of CVS Health by 400.0% during the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after purchasing an additional 400 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Insider Buying and Selling at CVS Health

In other news, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the sale, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 0.25% of the company’s stock.

CVS Health Trading Up 0.4 %

Shares of NYSE:CVS traded up $0.33 during midday trading on Thursday, hitting $79.76. 8,872,358 shares of the stock were exchanged, compared to its average volume of 11,297,311. The business’s 50-day moving average price is $75.66 and its 200 day moving average price is $73.46. The stock has a market capitalization of $100.37 billion, a price-to-earnings ratio of 12.37, a P/E/G ratio of 1.05 and a beta of 0.51. CVS Health Co. has a 12 month low of $64.41 and a 12 month high of $83.25. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.86.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.01 by $0.11. The firm had revenue of $93.81 billion during the quarter, compared to analysts’ expectations of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The company’s revenue was up 11.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.99 EPS. Analysts predict that CVS Health Co. will post 8.33 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.34%. The ex-dividend date is Friday, April 19th. CVS Health’s payout ratio is presently 41.18%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on CVS shares. TD Cowen cut their price target on CVS Health from $102.00 to $99.00 and set an “outperform” rating for the company in a research note on Monday, December 11th. HSBC began coverage on CVS Health in a research report on Friday, December 22nd. They set a “buy” rating and a $94.00 target price for the company. StockNews.com cut CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $87.00 price objective on shares of CVS Health in a research report on Thursday, February 8th. Finally, Piper Sandler raised their target price on shares of CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Friday, March 15th. Four research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $90.21.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.